| Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals F Conti, F Buonfiglioli, A Scuteri, C Crespi, L Bolondi, P Caraceni, ... Journal of hepatology 65 (4), 727-733, 2016 | 1018 | 2016 |
| A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C S Brillanti, J Garson, M Foli, K Whitby, R Deaville, C Masci, M Miglioli, ... Gastroenterology 107 (3), 812-817, 1994 | 399 | 1994 |
| Persistent hepatitis C viraemia without liver disease S Brillanti, M Foli, S Gaiani, C Masci, M Miglioli, L Barbara The Lancet 341 (8843), 464-465, 1993 | 247 | 1993 |
| Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? M Vivarelli, R Bellusci, A Cucchetti, G Cavrini, N De Ruvo, AA Aden, ... Transplantation 74 (12), 1746-1751, 2002 | 213 | 2002 |
| Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C S Brillanti, F Levantesi, L Masi, M Foli, L Bolondi Hepatology 32 (3), 630-634, 2000 | 183 | 2000 |
| Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation S Brillanti, M Vivarelli, N De Ruvo, AA Aden, V Camaggi, A D'Errico, ... Liver Transplantation 8 (10), 884-888, 2002 | 150 | 2002 |
| Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study S Brillanti, JA Garson, PW Tuke, C Ring, M Briggs, C Masci, M Miglioli, ... Journal of Medical Virology 34 (2), 136-141, 1991 | 113 | 1991 |
| Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C S Brillanti, C Masci, P Ricci, M Miglioli, L Barbara Hepatology 15 (6), 998-1001, 1992 | 105 | 1992 |
| Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience. S Brillanti, M Miglioli, L Barbara Journal of hepatology 23, 13-5; discussion 15, 1995 | 98 | 1995 |
| Rectal cell proliferation and colon cancer risk in ulcerative colitis G Biasco, GM Paganelli, M Miglioli, S Brillanti, G Di Febo, G Gizzi, ... Cancer research 50 (4), 1156-1159, 1990 | 91 | 1990 |
| Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ... Gut 71 (3), 593-604, 2022 | 78 | 2022 |
| Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis M Renzulli, F Buonfiglioli, F Conti, S Brocchi, I Serio, FG Foschi, ... European radiology 28, 506-513, 2018 | 77 | 2018 |
| Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C P Pontisso, MG Ruvoletto, M Nicoletti, S Tisminetzky, M Gerotto, ... Journal of viral hepatitis 2 (1), 33-38, 1995 | 74 | 1995 |
| Serological and histological aspects of hepatitis C virus infection in alcoholic patients S Brillanti, C Masci, S Siringo, G Di Febo, M Miglioli, L Barbara Journal of hepatology 13 (3), 347-350, 1991 | 73 | 1991 |
| Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals F Ravaioli, F Conti, S Brillanti, P Andreone, G Mazzella, F Buonfiglioli, ... Digestive and Liver Disease 50 (6), 573-579, 2018 | 70 | 2018 |
| Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders. S Brillanti, M Foli, M Di Tomaso, L Gramantieri, C Masci, L Bolondi Italian Journal of Gastroenterology and Hepatology 31 (2), 130-134, 1999 | 70 | 1999 |
| Hepatitis C virus: a possible cause of chronic hepatitis in alcoholics S Brillanti, L Barbara, M Miglioli, F Bonino The Lancet 334 (8676), 1390-1391, 1989 | 70 | 1989 |
| Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older F Conti, S Brillanti, F Buonfiglioli, R Vukotic, MC Morelli, C Lalanne, ... Journal of viral hepatitis 24 (6), 454-463, 2017 | 65 | 2017 |
| Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C JA Garson, K Whitby, R Deaville, S Brillanti, M Foli, C Masci, M Miglioli, ... Journal of medical virology 45 (3), 348-353, 1995 | 61 | 1995 |
| Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis JA Garson, S Brillanti, C Ring, P Perini, M Miglioli, L Barbara Journal of medical virology 37 (3), 210-214, 1992 | 59 | 1992 |
giuseppe mazzellaProfessor of Gastroenterology University of BolognaVerified email at unibo.it
